Focus on Furosemide

Thank you for listening!

The controversial subject of furosemide, the anti-bleeder medication widely used in North American racing, will be the subject of the next "Talkin' Horses with The Blood-Horse" live podcast at 2 p.m., Tuesday, June 26 on BloodHorse.com/TalkinHorses.

During the podcast, the medication marketed under the trade name Salix and formerly known as Lasix will be discussed by Dr. J. David Richardson and Dr. Foster Northrop. The podcast will be moderated by Tom LaMarra, news editor of The Blood-Horse magazine and BloodHorse.com, and Ron Mitchell, online managing editor at Bloodhorse.com.

Richardson is chairman of the Thoroughbred Owners and Breeders Association’s American Graded Stakes Committee and a member of the Breeders’ Cup board of members. The AGCS has endorsed a race-day ban on Salix in graded stakes for 2-year-olds and Breeders’ Cup intends to ban race-day Salix in its 2-year-old World Championships stakes this fall.

Richardson will be followed on the podcast by Northrop, a racetrack veterinarian and member of the Kentucky Horse Racing Commission. Northrop voted against the KHRC’s recent approval of an administrative regulation that would ban the use of furosemide on race-day in graded and listed stakes over a three-year period beginning Jan. 1, 2014.

Thank you for your questions.